LexDanaLexDanabeta
Inventor

ROBERTO MARIANI

Inventor
US

Overview

4→
Patents
2022–2024
Patent span
Human necessities
Primary field (CPC A)

Patents· 4 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes24%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
C07KPeptides24%
C12NMicroorganisms or enzymes24%
Y02ATechnologies for adaptation to climate change6%
PatentTitleYear
11,993,633Conformationally stabilized RSV pre-fusion F proteins202411,993,637Modified FGF-21 polypeptides with non-naturally encoded amino acids202411,926,649Conformationally stabilized RSV pre-fusion F proteins202411,267,848Conformationally stabilized RSV pre-fusion F proteins2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2024Patents assigned to CALDER BIOSCIENCES INC (3)· patent assignee history
2022–2024Based in US· patent location history
2024Patents assigned to AMBRX INC (1)· patent assignee history
2024Patents assigned to US HEALTH (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
CALDER BIOSCIENCES INC32022–2024
AMBRX INC12024
US HEALTH12024
Locations
LocationPatentsSpan
US42022–2024